... 种治疗方案对消化性溃疡患者幽门螺杆菌的根除疗效比较 前言： 将85例有幽门螺杆菌感染(Hp)感染的消化性溃疡(pepitic ulcer,PU)患者随机分成两组,观察组使用雷贝拉唑、左氧氟沙星、阿莫西林三联疗法;对照组使用雷贝拉唑、枸橼酸铋钾(...
基于6个网页-相关网页
幽门螺杆菌感染被认为是慢性胃炎、消化性溃疡、胃癌和胃malt淋巴瘤发病机制中的一个必然因素。
H. pylori infection is recognized as a causal factor in the pathogenesis of chronic gastritis, peptic ulcer, gastric cancer, and gastric MALT lymphoma.
BPD后的早期并发症包括1例肺部感染(4.5%)和一例伤口感染(4.5%)；晚期并发症包括三例切口疝(13.6%)和两例消化性溃疡(9.1%)。
Early complications after BPD included one pulmonary infection (4.5%) and one wound infection (4.5%); late complications included three incisional hernias (13.6%) and two peptic ulcers (9.1%).
详细论述了心血管药物、抗感染药、中枢神经系统药物、消化性溃疡药物、抗肿瘤药和药物新剂型的研究现状及动态，以及这几类药物市场的前景预测。
The current situation and trends of cardiovasculars, anti-infectives, CNS drugs, anti-ulcers, anti-cancers and new formulations as well as market prediction were also described.
应用推荐